Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
IDP:FRA
Biogen Inc
€ 159.16
-0.81%
(-1.30) Siku 1
4 Mei, 08:58:24 GMT +2  ·   EUR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya IDP...
Fungua
€ 159.16
Juu
€ 159.16
Chini
€ 159.16
Mtaji wa soko
27.62B
Wastani wa kiasi cha mauzo
23.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 169.30
Chini kwa wiki 52
€ 102.65
Idadi ya wafanyakazi
elfu 8
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel fumarate, interferon beta-1a, peginterferon beta-1a, and natalizumab, all for the treatment of multiple sclerosis; nusinersen for the treatment of spinal muscular atrophy; omaveloxolone for the treatment of Friedreich's ataxia; tofersen for the treatment of ALS; and dimethyl fumarate for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs. The company is ranked 424th on the Fortune 500 and 845th on the Forbes Global 2000. Wikipedia
Kuhusu Biogen Inc
Afisa Mkuu Mtendaji (CEO)Chris Viehbacher
Wafanyakazielfu 7.5
Lilianzishwa1978
Makao makuuCambridge, Massachusetts, Marekani
Sekta-
Tovutibiogen.com
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Jun 2025
Sep 2025
Des 2025
Mac 2026
Mapato
2.65B
2.53B
2.28B
2.48B
Gharama ya bidhaa zilizouzwa
946.20M
508.60M
443.40M
610.20M
Gharama ya mapato
946.20M
508.60M
443.40M
610.20M
Gharama za utafiti na maendeleo
-
431.80M
501.00M
482.20M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
581.30M
592.80M
685.20M
607.30M
Gharama ya uendeshaji
783.70M
1.25B
1.39B
1.30B
Jumla ya gharama za uendeshaji
1.73B
1.76B
1.83B
1.91B
Mapato ya uendeshaji
915.60M
778.60M
447.70M
567.40M
Mapato mengine yasiyo ya uendeshaji
-3.30M
15.80M
17.40M
-1.10M
EBT ikijumuisha vipengee visivyo vya kawaida
744.00M
557.30M
-56.00M
377.70M
EBT bila kujumuisha vipengee visivyo vya kawaida
861.60M
748.30M
423.10M
530.10M
Gharama ya kodi ya mapato
109.20M
90.80M
-7.10M
58.20M
Kiwango cha kodi kinachotumika
14.68%
16.29%
12.68%
15.41%
Gharama nyingine za uendeshaji
75.00M
87.20M
69.90M
74.20M
Mapato halisi
634.80M
466.50M
-48.90M
319.50M
Kiwango cha faida halisi
24.00%
18.40%
-2.15%
12.89%
Mapato kwa kila hisa
5.47
4.81
1.99
3.57
Mapato ya riba na uwekezaji
32.30M
31.60M
37.20M
37.90M
Gharama ya riba
-72.60M
-67.40M
-67.50M
-67.60M
Jumla ya gharama halisi za riba
-40.30M
-35.80M
-30.30M
-29.70M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
1.11B
980.80M
647.90M
771.80M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho